FIELD: pharmaceutical industry.
SUBSTANCE: invention for the pharmaceutical industry, namely, a composition for the recovery and prevention of diseases selected from influenza, acute respiratory infections, acute respiratory viral infections, inflammatory, bacterial diseases of the upper respiratory tract, skin and mucous membranes. Composition for the recovery and prevention of diseases selected from influenza, acute respiratory infections, acute respiratory viral infections, inflammatory, bacterial diseases of the upper respiratory tract, skin and mucous membranes, containing an alcoholic extract of propolis and an alcoholic extract from wax moth larvae, characterized in that it also contains an alcoholic extract of resin, alcoholic gum extract, alcoholic extract of stone oil and aqueous solution of mummy, malachite concentrate, alcoholic plant extract obtained from plant materials, including: chamomile flowers, sage flowers, licorice root, burdock root, plantain leaf, horsetail grass, dandelion root, in the following ratio components, wt.%: alcohol extract of propolis 15%; alcohol extract from wax moth larvae 15%; alcohol extract of resin 3.5%; alcohol extract of gum 5%; alcohol extract of stone oil 10%; mummy water 10% solution 10%; malachite concentrate 5%; alcoholic plant extract 36.5%, obtained from vegetable raw materials, including the following ratio of components based on 100% raw materials: chamomile flowers 25%, sage flowers 15%, licorice root 15%, burdock root 15%, plantain leaf 15%, horsetail herb 5%, dandelion root 10%.
EFFECT: above composition is effective for the recovery and prevention of diseases selected from influenza, acute respiratory infections, acute respiratory viral infections, inflammatory, bacterial diseases of the upper respiratory tract, skin and mucous membranes.
1 cl, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OINTMENT WITH BEE MOTH LARVAE EXTRACT AND PROPOLIS EXTRACT FOR PREVENTION AND INTEGRATED TREATMENT OF VIRAL INFECTION | 2011 |
|
RU2477141C2 |
| MEANS FOR TREATMENT OF SKIN AND MUCOSA DISEASES, FOR LOCAL USE, WHICH IS ANTI-INFLAMMATORY, ANTI-BACTERIAL, ANTIVIRAL, WOUND-HEALUNG, ANTI-FUNGAL | 2016 |
|
RU2626673C1 |
| MEANS FOR SKIN DISEASES TREATMENT HAVE ANTI-INFLAMMATORY, WOUND-HEALING, ANTIBACTERIAL, ANTI-VIRAL, ANTI-FUNGAL ACTION | 2016 |
|
RU2623061C1 |
| METHOD FOR VIRAL INFECTION CONTROL | 2019 |
|
RU2749968C2 |
| PHARMACEUTICAL AGENT OF PLANT ORIGIN IN THE FORM OF A SPRAY | 2022 |
|
RU2801872C1 |
| COMPOSITIONS FOR TREATING UPPER AIRWAYS DISEASES AND INFLUENZA SYMPTOM COMPLEX | 2009 |
|
RU2518738C2 |
| AGENT FOR ENDOECOLOGICAL REHABILITATION | 2014 |
|
RU2571287C1 |
| DENTAL PHYTOFILMS FOR TREATMENT OF TRAUMATIC LESIONS OF THE ORAL MUCOSA DURING ORTHODONTIC TREATMENT | 2017 |
|
RU2651706C1 |
| DENTAL GEL WITH PROBIOTIC FOR THE TREATMENT OF INFLAMMATORY DISEASES OF PERIODONTAL TISSUES AND ORAL DYSBIOSIS | 2021 |
|
RU2760275C1 |
| DENTAL GEL WITH A PHYTOPELOID COMPOSITION | 2019 |
|
RU2699560C1 |
